Knight Therapeutics
From Wikipedia, the free encyclopedia
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange (symbol GUD), with a market capitalization of $1.02 billion as of August 2019.[1]
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
TSX: GUD S&P/TSX Composite Component | |
Founded | 1995 |
Founder | Jonathan Ross Goodman |
Headquarters | , Canada |
Key people | Jonathan Ross Goodman (Executive Chairman) Samira Sakhia (CEO) |
Revenue | $243.478 million (2021) |
Website | gud-knight |
Close